There is an association of dysfunctional estrogen metabolism in the pathophysiology of PAH; an increase in estrogen metabolites, including 16OHEs and CYP1B1, have been shown to be associated with the development of PAH [20,21]. This evidence concerns the gene CYP1B1 and pulmonary arterial hypertension.